(86 days)
Not Found
No
The device description and performance studies focus on mechanical and electrical components, with no mention of AI/ML, image processing, or data-driven algorithms.
Yes
The device is indicated for "resection and ablation of varicose veins," which are therapeutic procedures aimed at treating a medical condition.
No
The provided text describes the device as being "Indicated for use in ambulatory phlebectomy procedures for resection and ablation of varicose veins," which are treatment procedures, not diagnostic ones.
No
The device description explicitly lists multiple hardware components (control unit, pumps, illuminator, handpiece, footswitches), indicating it is a hardware-based system, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "ambulatory phlebectomy procedures for resection and ablation of varicose veins." This describes a surgical procedure performed directly on a patient's body, not a test performed on a sample taken from the body.
- Device Description: The components listed (control unit, pumps, illuminator, resector handpiece, footswitches) are all consistent with surgical equipment used for physical intervention, not for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), performing tests, or providing diagnostic information based on laboratory analysis.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for diagnosis, monitoring, or screening. This device's function is to physically remove or ablate varicose veins.
N/A
Intended Use / Indications for Use
Indicated for use in ambulatory phlebectomy procedures for resection and ablation of varicose veins.
Product codes
DWQ
Device Description
The Smith & Nephew TriVex™ System consists of a control unit mounted on a pedestal stand, dual peristaltic pumps, an illuminator, resector handpiece and footswitches.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The Smith & Nephew TriVex™ System meets the biocompatibilty requirements of ISO 10993-1 and electrical safety standards for BF type equipment as stated in UL 60601-1 and IEC 60601-1.
Key Metrics
Not Found
Predicate Device(s)
K990723, K991323, K994084, K012044
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.4885 External vein stripper.
(a)
Identification. An external vein stripper is an extravascular device used to remove a section of a vein.(b)
Classification. Class II (performance standards).
0
Endoscopy Smith & Nephew, Inc 150 Minuteman Road Andover, MA 01810
978 749 1000 978 749 1599 Fax www.smith-nephew.com OCT 2 9 2003
K032387(pg 1 of 2)
SECTION IV
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION
as required by the Safe Medical Devices Act of 1990 and codified in 21 CFR 807.92 upon which the substantial equivalence is based.
Date Prepared: July 31, 2003
A. Submitter's Name:
Smith & Nephew, Inc., Endoscopy Division 150 Minuteman Road Andover, MA 01810
B. Company Contact:
Karen Provencher Regulatory Affairs Specialist Phone: 978-749-1365 Fax: 978-749-1443
C. Device Name
| Trade Name: | Smith & Nephew TriVex TM System |
|---|---|
| Common Name: | Varicose Vein Ablation System |
| Classification Name: | Stripper, Vein, External |
D. Predicate Devices
- The Smith & Nephew TriVex™ System is substantially equivalent in Intended Use and Fundamental Scientific Technology to the following legally marketed device in commercial distribution: The Dyonics® Varicose Vein Ablation System - K990723, Subcutaneous Illuminator - K991323, Smith & Nephew Xenon Light Source -K994084, and H.K. Surgical Klein Pump - K012044.
Smith & Nephew TriVex™ System Page 29 of 308
1
E. Description of Device
The Smith & Nephew TriVex™ System consists of a control unit mounted on a pedestal stand, dual peristaltic pumps, an illuminator, resector handpiece and footswitches.
F. Intended Use
The proposed Smith & Nephew TriVex™ System is indicated for use in ambulatory phlebectomy procedures for the resection and ablation of varicose veins.
G. Comparison of Technological Characteristics
The Smith & Nephew TriVex™ System is substantially equivalent in design. materials, function and intended use to the following devices cleared for commercial distribution:
- The Dyonics® Varicose Vein Ablation System - K990723
- Subcutaneous Illuminator - K991323
- Smith & Nephew Xenon Light Source K994084 ●
- H.K. Surgical Klein Pump - K012044
G. Summary Performance Data
The Smith & Nephew TriVex™ System meets the biocompatibilty requirements of ISO 10993-1 and electrical safety standards for BF type equipment as stated in UL 60601-1 and IEC 60601-1.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The symbol is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter of the circle. The text is written in a sans-serif font.
Public Health Service
OCT 2 9 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ms. Karen Provencher Regulatory Affairs Specialist Smith & Nephew , Inc. Endoscopy Division 150 Minuteman Road Andover, Massachusetts 01810
Re: K032387
Trade/Device Name: Smith & Nephew TriVex™ System Regulation Number: 21 CFR 870.4885 Regulation Name: External vein stripper Regulatory Class: II Product Code: DWQ Dated: July 31, 2003 Received: August 4, 2003
Dear Ms. Provencher:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Insting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Ms. Karen Provencher
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Miriam C. Provost
to Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known):
KC32387
Smith & Nephew TriVex™ System_ Device Name: _________________________________________________________________________________________________________________________________________________________________
Indications For Use:
Indicated for use in ambulatory phlebectomy procedures for resection and ablation of varicose veins.
Muriam C. Provost
(Division Sign-Off) Division of General, Restorative and Neurological Devices
510(k) Number K632387
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
Smith & Nephew TriVex™ System Page 14 of 308